These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33105934)

  • 1. [Analysis of the clinical value of ultrasound attenuation parameters in evaluating liver steatosis degree in patients with chronic liver disease].
    Qiao J; Zhao W; Du JH; Zhang SY; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):876-881. PubMed ID: 33105934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
    Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease].
    An XY; Qiao J; Hu LX; Wang RQ; Nan YM
    Zhonghua Nei Ke Za Zhi; 2023 Jan; 62(1):49-53. PubMed ID: 36631037
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease].
    Wang R; Ren W; Zhao S; Niu X; Tan P; Du H; Nan Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):265-9. PubMed ID: 26133817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Qu Y; Song YY; Chen CW; Fu QC; Shi JP; Xu Y; Xie Q; Yang YF; Zhou YJ; Li LP; Xu MY; Cai XB; Zhang QD; Yu H; Fan JG; Lu LG
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00323. PubMed ID: 33848277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 7. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
    Chen XL; Han YD; Wang H
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5640-5646. PubMed ID: 30229840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease.
    Zhu SH; Zheng KI; Hu DS; Gao F; Rios RS; Li G; Li YY; Byrne CD; Targher G; Chen YP; Zheng MH
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):430-435. PubMed ID: 32398489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C.
    Valkov I; Ivanova R; Alexiev A; Antonov K; Mateva L
    J Clin Diagn Res; 2017 Aug; 11(8):OC15-OC20. PubMed ID: 28969178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
    Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
    Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test.
    Guzzaloni G; Grugni G; Minocci A; Moro D; Morabito F
    Int J Obes Relat Metab Disord; 2000 Jun; 24(6):772-6. PubMed ID: 10878685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical features and identification of risk factors in patients with non-alcoholic fatty liver disease based on FibroTouch.
    Liao Y; Liu L; Yang J; Zhou X; Teng X; Li Y; Wan Y; Yang J; Shi Z
    Sci Rep; 2023 Sep; 13(1):14812. PubMed ID: 37684380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.
    Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Marczyńska M
    BMC Infect Dis; 2017 May; 17(1):361. PubMed ID: 28535787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.